ORUVAIL

This brand name is authorized in Australia, Ireland, New Zealand, UK.

Active ingredients

The drug ORUVAIL contains one active pharmaceutical ingredient (API):

1	Ketoprofen UNII 90Y4QC304K - KETOPROFEN
	Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions.
	Read more about Ketoprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ORUVAIL Controlled release capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ORUVAIL Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE03	Ketoprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1590Q, 5136H
GB	Medicines & Healthcare Products Regulatory Agency	146717, 27344, 27387, 27442, 373995
IE	Health Products Regulatory Authority	38040
NZ	Medicines and Medical Devices Safety Authority	1804